PCG Digital

Recent News

  • Highlights and Insights into Soligenix

    New York, New York--(Newsfile Corp. - October 13, 2021) - PCG Digital -- In a recent interview with Kristen Kluska, a biotechnology analyst at Cantor, Dr. Chris Schaber, President and CEO of Soligenix (NASDAQ: SNGX), spoke about the latest developments with their synthetic hypericin topical treatment HyBryte™ and the Company's ongoing research and development of thermostabilized vaccine candidates for filoviruses and COVID-19. The interview took place at the Cantor Fitzgerald Global Health Care Conference, which was held virtually from...

    2021-10-13 8:30 AM EDT
  • Vaccine from Soligenix Could Accelerate Global Recovery from COVID-19 Pandemic

    New York, New York--(Newsfile Corp. - October 7, 2021) - PCG Digital -- Shipping and administering COVID-19 vaccines that need to be stored at sub-zero temperatures is hampering the pandemic recovery efforts of health professionals around the world. Soligenix, Inc (NASDAQ: SNGX), a US-based late-stage biopharmaceutical company, is developing a solution to that problem. The Company hit another key milestone this week with its heat-stable vaccine program, CiVax™.On Sept 28, Soligenix announced efficacy test results of CiVax™ on non-human primates. CiVax™...

    2021-10-07 8:30 AM EDT
  • DehydraTECH(TM) Nicotine Pouches Could Make Smoking Obsolete

    New York, New York--(Newsfile Corp. - October 5, 2021) - PCG Digital -- Lexaria Bioscience Corp (NASDAQ: LEXX) is making headlines again this week. In a study conducted by a leading independent testing facility, DehydraTECH™ 2.0 nicotine pouches easily outperformed generic nicotine benzoate pouches, hitting peak delivery rates within eight minutes, and then again at thirty minutes. The generic pouches hit peak at forty-five minutes.It's a significant disparity when comparing two similar products, but Lexaria already knows their technology works....

    2021-10-05 10:48 AM EDT
  • Nightfood Sleep-Friendly Snacks Enter Hospitality Industry, Helping Hotels Deliver Better Sleep for Guests

    TakeawaysNightfood (OTCQB: NGTF), which solves the $50 billion problem of unhealthy nighttime snacking, successfully concluded a retail pilot test in lobby shops of a global hotel chainThat chain will be rolling Nightfood into their grab-and-go freezers in coming monthsThe brand has engaged iDEAL Hospitality Partners to secure additional hotel distribution partnershipsNightfood believes hotel distribution will greatly advance supermarket sales in the short and long termThe hotel news has not yet moved Nightfood's OTC stockNew York, New York--(Newsfile Corp. - September...

    2021-09-21 8:30 AM EDT
  • Soligenix Develops Groundbreaking Vaccine Platform to Target Future Pandemics

    New York, New York--(Newsfile Corp. - September 14, 2021) - PCG Digital -- The COVID-19 pandemic has already cost the United States an estimated $16 trillion in lost economic output, and has resulted in the loss of over 600,000 lives. At the end of last month, the country reached the dubious milestone of 39 million diagnosed cases of COVID, however, researchers have estimated a further 4.8 undiagnosed cases per diagnosis, bringing the nation's total number of infections closer to 200...

    2021-09-14 8:30 AM EDT
  • Lexaria Takes Another Step Towards NDA Filing for DehydraTECH- CBD

    New York, New York--(Newsfile Corp. - September 14, 2021) - PCG Digital -- The most recent results from HYPER-H21-2, a human clinical study of the effects of Lexaria's DehydraTECHTM-processed CBD on blood pressure (BP) over a 24-hour ambulatory period, have moved the needle significantly in Lexaria's path towards an eventual New Drug Application (NDA). As a precursor to that, the company has begun an Investigational New Drug (IND) enabling program.Volunteers for HYPER-H21-2 who cope with mild to moderate hypertension averaged...

    2021-09-14 8:30 AM EDT
  • Winning Formulation; Lexaria Takes Strategic Aim at High Value Hypertension and Antiviral Therapeutics Markets with Robust Drug Delivery Technology

    Lexaria, delivering active ingredients to patients, could deliver for investors tooThe company that turns CBD into blood pressure control might be poised for a surgeTakeawaysOne critical component to over-the-counter drugs is how efficiently and how quickly (or not) they enter the bloodstream.Lexaria's DehydraTECHTM platform has proven to be an effective method to deliver active ingredients, with human tests demonstrating its ability with CBD as a hypertension treatment and animal tests demonstrating its ability with various antivirals.DehydraTECH enabled products are on...

    2021-08-17 8:30 AM EDT
  • Who Is Preparing Us for the Next Potential Pandemic?

    New York, New York--(Newsfile Corp. - July 29, 2021) - -- PCG Digital -- Dr. Fauci said it publicly this week, but we've all been thinking it for months now. COVID-19 did not hit us, "out of the blue." Scientists, medical professionals, and researchers have been expecting this for years. The global pandemic was no surprise to them.It will happen again. That's not prophetic gloom and doom. It's scientific fact. With the number of communicable diseases and viruses currently out...

    2021-07-29 8:30 AM EDT